Project 2: Mechanisms of Induction of Tolerance to Murine Heart Allografts by Kidney Allografts

项目2:同种异体肾诱导小鼠心脏同种异体移植耐受的机制

基本信息

  • 批准号:
    9326135
  • 负责人:
  • 金额:
    $ 41.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Kidney allografts are naturally tolerogenic in mice. Mice develop tolerance of kidney allografts across full MHC incompatibilities without immunosuppression. This tolerance is initially dependent Foxp3+ cells which are concentrated in the graft in distinctive Treg-rich organized lymphoid structures (TOLS). Recipients of allograft kidneys develop systemic tolerance to skin and heart allografts. This project will identify the immunobiologic features for induction of heart allograft tolerance by kidney allografts in a sequential series of experiments that will determine the timing of systemic tolerance, the dependence on the continued presence of the allograft kidney and thymus, whether the kidney promotes regulatory and/or deletional tolerance and the hypothesized role of kidney dendritic cells, tubular cells and kidney related mediators. We will test for dependence on Foxp3+ cells using B6.Foxp3DTR recipients. We will test whether generation of Foxp3+ cells is related to donor DCs in the kidney and whether adoptively transferred plasmacytoid DCs (pDCs) from the kidney are sufficient to induce acceptance of heart allografts. Renal tubular epithelial cells (RTEC) will be tested in vitro and in vivo for their ability to promote differentiation into Treg and whether selective RTEC injury affects tolerance induction. Infiltrates in cardiac allografts with or without co-transplanted kidneys will be compared for presence of TOLS, pDCs and activated Treg. Finally the mechanisms responsible for the resistance of kidney allografts to sensitized T cells will sought, whether the kidney promotes conversion of T cells to Treg or inactivates or deletes T cells, or is resistant to their action. The kinetics and distribution of Treg and sensitized T cells in the grafts, lymphoid organs and blood will be assessed using in vivo bioluminescence imaging. The fate of the transferred cells in the kidney allograft and their interactions with DCs will be assessed. These studies are expected to reveal mechanisms by which the kidney promotes tolerance of heart grafts, thereby helping to clarify and interpret the observations made in Projects 1 and the EPO experiments in Project 3 and guide the development of clinically applicable treatment protocols.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert B Colvin其他文献

Robert B Colvin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert B Colvin', 18)}}的其他基金

Immunopathologic Studies
免疫病理学研究
  • 批准号:
    8432088
  • 财政年份:
    2012
  • 资助金额:
    $ 41.22万
  • 项目类别:
Immunopathologic Studies
免疫病理学研究
  • 批准号:
    8725788
  • 财政年份:
    2012
  • 资助金额:
    $ 41.22万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    8071240
  • 财政年份:
    2010
  • 资助金额:
    $ 41.22万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    8260821
  • 财政年份:
    2010
  • 资助金额:
    $ 41.22万
  • 项目类别:
Pathology
病理
  • 批准号:
    8134128
  • 财政年份:
    2010
  • 资助金额:
    $ 41.22万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    8462892
  • 财政年份:
    2010
  • 资助金额:
    $ 41.22万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    7985705
  • 财政年份:
    2010
  • 资助金额:
    $ 41.22万
  • 项目类别:
Immunopathology
免疫病理学
  • 批准号:
    7680751
  • 财政年份:
    2009
  • 资助金额:
    $ 41.22万
  • 项目类别:
Mechanisms of acceptance of mouse renal allografts
小鼠同种异体肾移植物的接受机制
  • 批准号:
    7848042
  • 财政年份:
    2009
  • 资助金额:
    $ 41.22万
  • 项目类别:
Core--Pathology
核心--病理学
  • 批准号:
    7009886
  • 财政年份:
    2005
  • 资助金额:
    $ 41.22万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 41.22万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 41.22万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 41.22万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 41.22万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 41.22万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 41.22万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 41.22万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 41.22万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 41.22万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 41.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了